Telomir Pharmaceuticals is a preclinical stage company that is focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. Preclinical tests have shown encouraging results, with telomere caps being extended and examples of Telomir-1, the company's primary treatment, working to improve patient outcomes.
